(Q34364855)

1 August 2017

1 reference

title

Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view (English)

1 reference

1 August 2017

D Schmidt

1

1 reference

1 August 2017

S Arroyo

2

1 reference

1 August 2017

M Baulac

3

1 reference

1 August 2017

M Dam

4

1 reference

1 August 2017

O Dulac

5

1 reference

1 August 2017

M L Friis

6

1 reference

1 August 2017

R Kälviäinen

7

1 reference

1 August 2017

G Krämer

8

1 reference

1 August 2017

J van Parys

9

1 reference

1 August 2017

B Pedersen

10

1 reference

1 August 2017

R Sachdeo

11

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Acta Neurologica Scandinavica

1 August 2017

1 reference

1 August 2017

104

1 reference

1 August 2017

3

1 reference

1 August 2017

167-170

1 reference

Oxcarbazepine for Treatment of Partial Epilepsy: A Review and Recommendations for Clinical Use

1 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

Monotherapy trials of new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

Hyponatremic coma under oxcarbazepine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

21 January 2018

Oxcarbazepine: a review

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

7 January 2021

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

7 January 2021

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

7 January 2021

A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

7 January 2021

Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

7 January 2021

Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

7 January 2021

Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

7 January 2021

Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

7 January 2021

The new antiepileptic drugs: a systematic review of their efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

7 January 2021

Hyponatraemia during oxcarbazepine therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00870.X

7 January 2021

10.1034/J.1600-0404.2001.00870.X

Identifiers

DOI

1 reference

1 August 2017

1 reference